Article Information
History
- May 27, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- A Hutchinson1,
- R Pais1,
- AN Edginton2,
- B Pilon3,
- JM MacDonald4,
- ME MacDonald4,
- T Lewis1,5,
- M Offringa6,7 and
- BT Kalish1,7,8,*
- 1Division of Neonatology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, M5G 1X8, Canada
- 2School of Pharmacy, University of Waterloo, 10 Victoria St S A, Kitchener, ON, N2G 1C5, Canada
- 3Hope for HIE, West Bloomfield, Michigan, USA
- 4Patient Family Advocate
- 5Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, ON, Canada
- 6Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, ON, Canada
- 7Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, M5S 1A1, Canada
- 4Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada
- 7Department of Molecular Genetics, University of Toronto, 555 University Avenue, Toronto, ON, M5G 1X8, Canada
- 8Program in Neuroscience and Mental Health, SickKids Research Institute, 686 Bay Street, Toronto, ON M5G 1L7, Canada
- ↵* Corresponding author; email: bkalish1{at}gmail.com
Posted May 27, 2024.
A Safety and Feasibility Trial Protocol of Metformin in Infants after Perinatal Brain Injury
